Roberta Baronio

2.6k citations
21 papers · 1.8k · 1 hit paper · h-index 13

Impact in

    • Breast Cancer Treatment Studies
  • Oncology top 5%
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology
    • Cancer-related Molecular Pathways
    • Peptidase Inhibition and Analysis

Papers in

    • RNA modifications and cancer 5
    • Protein Degradation and Inhibitors 2
    • Genomics and Phylogenetic Studies 2
    • RNA Research and Splicing 2
    • Cancer-related Molecular Pathways 3

Roberta Baronio

19 papers receiving 1.8k citations

Roberta Baronio's Hit Papers

Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort 2010 · 891 citations
8910+5+10Years since publication250500750

Peers

Roberta Baronio
Comparison fields: 5 of 106
  • Cancer Research 576
  • Oncology 940
  • Radiology, Nuclear Medicine and Imaging 291
  • Hematology 116
  • Molecular Biology 659
Replace David Verbel with:
David Verbel United States
Michael J. Wick United States
Andrea Bild United States
Mohamed E. Abazeed United States
K. Anderson United States
Elton Rexhepaj Ireland
Curtis R. Pickering United States
Keyan Salari United States
David Harpole United States
Christina Yau United States
Roberta Baronio relative to David Verbel United States David Verbel's profile →
Citations per field
00.5×1.5×1.8×
David Verbel · 1×
Citations per year

Countries citing papers authored by Roberta Baronio

Since Specialization
Citations

This map shows the geographic impact of Roberta Baronio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Baronio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Baronio more than expected).

Fields of papers citing papers by Roberta Baronio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta Baronio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Baronio. The network helps show where Roberta Baronio may publish in the future.

Co-authors

The 25 scholars most cited alongside Roberta Baronio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Roberta Baronio Line = papers co-authored together Roberta Baronio links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort
Hit paper breakdown →
2010891
2 2013180
3 2011140
4 2015134
5 2015111
6 2013103
7 200287
8 200950
9 200744
10 201134
11 201016
12 201013
13
Countering Gattaca: Efficient and Secure Testing of Fully-Sequenced Human Genomes
201112
14 20249
15 20148
16 20127
17
Computational identification of a transiently open L1/S3 pocket for reactivation of mutant p53 - eScholarship
20136
18 20152
19 20241
20 20140

About Roberta Baronio

Roberta Baronio is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Physiology and Immunology, having authored 21 papers that have together received 1.8k indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), Asthma and respiratory diseases (4 papers), Inhalation and Respiratory Drug Delivery (4 papers), Respiratory and Cough-Related Research (4 papers), Cancer-related Molecular Pathways (3 papers), Protein Degradation and Inhibitors (2 papers), Genomics and Phylogenetic Studies (2 papers) and RNA Research and Splicing (2 papers). The work is most often cited by research in Cancer Research (576 citations), Oncology (940 citations), Radiology, Nuclear Medicine and Imaging (291 citations), Hematology (116 citations) and Molecular Biology (659 citations). Roberta Baronio has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Luca Gianni, Aňa Lluch, Milvia Zambetti, W. Eiermann, Alexey Manikhas, Miguel Ángel Climent, Mauro Mansutti, Mikhail Byakhow, Eva Ciruelos and Semiglazov Vf. Their work appears in journals such as PLoS Computational Biology, Pulmonary Pharmacology & Therapeutics, PLoS ONE, Nature Communications and The Lancet Respiratory Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact